CVS Offers New Care Management Program for Pulmonary Arterial Hypertension
A CVS subsidiary launched a program to help patients with pulmonary arterial hypertension (PAH) better manage their own care.
Category: Pulmonary Hypertension
Pulmonary Hypertension
Latest
Pulmonary Hypertension
Latest
Study: Diagnosing Pulmonary Hypertension Due to Left Heart Disease
In certain patients, measurements of pulmonary artery (PA) distensibility are more effective at detecting pulmonary hypertension due to left heart disease than measurements of PA dilatation.
Pulmonary Hypertension
Latest
Pulmonary Arterial Hypertension Patients Benefit from Macitentan + Tadalafil Combo
Patients newly diagnosed with pulmonary arterial hypertension treated with macitentan and tadalafil combination therapy showed hemodynamic progress, as well as improvements in function and risk profile.
Tumor-suppressing Protein May Be Novel Target in PAH Therapy
In addition to suppressing tumors, the protein tuberous sclerosis complex 2 (TSC2) may play a role in preventing or treating pulmonary arterial hypertension (PAH).
Read More
Selexipag Improved Clinical Outcomes in Pulmonary Arterial Hypertension
Treatment with selexipag versus placebo improved clinical outcomes in patients with pulmonary arterial hypertension (PAH) regardless of the time from diagnosis to drug initiation.
Read More
Pulmonary Arterial Hypertension Tied to Protein Production
Development of pulmonary arterial hypertension (PAH) may be related to increased production of Nestin protein in the pulmonary vasculature, a Plos One study reports.
Read More
Is Sex Predictive of Right Ventricular Dysfunction in Some PH Patients?
Research reports that male sex may be predictive of right ventricular dysfunction in some pulmonary hypertension patients.
Read More
RT Awareness and Preferences Regarding Pulmonary Hypertension Treatment
RTs may find it difficult to choose between available inhaled pulmonary vasodilators (IPVs)—inhaled nitric oxide or nebulized epoprostenol—to treat pulmonary hypertension.
Read More
Inhaled Nitric Oxide May Not Improve Survival of Preterm Infants
Preterm infants born younger than 29 weeks’ gestational age who were treated for pulmonary...
Read More
Lung Force Expo Coming to Kansas City
The American Lung Association will host a Lung Force Expo on June 15 in Kansas City, Mo.
Read More
Adenotonsillectomy Reduces Blood Pressure in Children With OSA, Hypertension
Adenotonsillectomy resulted in significant improvements in blood pressure for children suffering with obstructive sleep apnea (OSA) and hypertension.
Read More
Temple Performs Most Lung Transplants of any Hospital in US
Temple University Hospital performed 131 lung transplants in 2017, making it the highest-volume...
Read More
Genes on Y Chromosome Protect against Pulmonary Hypertension
The Y chromosome provides protection against pulmonary hypertension and may be the reason the disease is less prevalent among men than women.
Read More
Sarcoidosis-associated PH Linked to a Poor Prognosis
Patients with sarcoidosis frequently develop pulmonary hypertension, which is associated with an 8- to 10-fold increase in mortality among sarcoidosis patients.
Read More
Study: Beta Blockers Have Positive Effect in PAH
According to new research from Cleveland Clinic, the use of carvedilol, a beta blocker, had a positive effect on treatment of pulmonary arterial hypertension.
Read More